Skip to main content
$64.14 $0.55 (0.9%)

01:18 PM EDT on 05/16/22

Globus Medical (NYSE:GMED)

CAPS Rating: 4 out of 5

Current Price $64.14 Mkt Cap $6.5B
Open $63.28 P/E Ratio 45.32
Prev. Close $63.59 Div. (Yield) $0.00 (0.0%)
Daily Range $63.17 - $64.68 Volume 257,905
52-Wk Range $57.21 - $84.23 Avg. Daily Vol. 951,465

Caps

How do you think NYSE:GMED will perform against the market?

Add Stock to CAPS Watchlist

All Players

254 Outperform
9 Underperform
 

All-Star Players

21 Outperform
1 Underperform
 

Wall Street

0 Outperform
0 Underperform
 

Top NYSE:GMED Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

Dsal14 (< 20)
Submitted July 26, 2020

currently profitable with slow steady growth... but are just breaking into the robotics surgery market with their new robotics surgery system for spine surgery - the first of its kind (ISRG is soft tissue, GMED is bone)

Top Bear Pitch

There are no pitches that meet the Top Bear criteria. Explain

If this upsets you, start recommending pitches below!

NYSE:GMED VS S&P 500 (SPY)

NYSE:GMED Summary

Fools bullish on NYSE:GMED are also bullish on:

Fools bearish on NYSE:GMED are also bearish on:

Recent Community Commentary

Read the most recent pitches from players about GMED.

Recs

0
Member Avatar KPowersUSMC (< 20) Submitted: 9/16/2021 4:17:26 PM : Outperform Start Price: $81.54 NYSE:GMED Score: -11.26

Bringing a new way into the medical field.

Recs

0
Member Avatar chessNstocks (< 20) Submitted: 8/30/2021 6:15:36 PM : Outperform Start Price: $82.25 NYSE:GMED Score: -10.50

From Fidelity July 2021
Revenue Growth (5YR) = 7.7%
Rev Change (Last Qtr vs Prior year Qtr) = 68.6%
Price/Sales (TTM) = 8.4

Recs

0
Member Avatar jjhegi (47.94) Submitted: 12/12/2020 9:58:53 PM : Outperform Start Price: $55.24 NYSE:GMED Score: -2.88

Growing revenues and profitable each of the last 5 years. Founder and CEO owns large chunk of the company and still closely involved. Already profitable and its new ExelciusGPS system could lead to explosive growth. Strong balance sheet and strong free cashflow makes this a low-risk bet with high reward potential.

Leaderboard

Find the members with the highest scoring picks in GMED.

Score Leader

pungocatfish

pungocatfish (< 20) Score: +312.42

The Score Leader is the player with the highest score across all their picks in GMED.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
pungocatfish < 20 1/3/2013 Outperform 3Y $10.94 +486.56% +174.14% +312.42 0 Comment
Squeege1981 69.23 12/24/2012 Outperform 3Y $10.96 +485.49% +180.90% +304.60 0 Comment
PerdidoBeacher 49.11 12/20/2012 Outperform 5Y $11.34 +465.87% +177.20% +288.67 0 Comment
Biotechnut < 20 12/3/2012 Outperform 5Y $12.05 +432.53% +182.38% +250.15 0 Comment
jayimsu < 20 4/30/2013 Outperform 5Y $14.79 +333.87% +151.28% +182.59 0 Comment
Santa007 < 20 8/15/2012 Outperform 3Y $14.32 +348.08% +184.09% +164.00 2 Comments
NewClueLess < 20 11/11/2013 Outperform 5Y $18.52 +246.49% +125.96% +120.53 0 Comment
jsnms 23.71 12/17/2013 Outperform 5Y $19.10 +235.97% +123.14% +112.83 0 Comment
sandvig 95.48 11/10/2016 11/1/2021 Outperform 5Y $21.61 +196.95% +84.18% +112.77 0 Comment
TravelinLight 21.87 12/31/2013 Outperform 5Y $20.01 +220.69% +117.18% +103.51 0 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

There are no Wall Street tracker picks for GMED.